The World Health Organization (WHO) has issued a significant new guideline concerning non-sugar sweeteners (NSS), often referred to as artificial or low-calorie sweeteners. Following a comprehensive review of available scientific evidence, the WHO is now advising against the routine use of NSS for the purpose of controlling body weight or reducing the risk of noncommunicable diseases such as type 2 diabetes and cardiovascular disease. This recommendation marks a notable shift in public health messaging regarding these widely consumed sugar substitutes.
Key Findings and Recommendations from the WHO Guideline
The core of the WHO’s updated guidance stems from a systematic review and meta-analysis of the scientific literature. The organization concluded that replacing sugar sweeteners with NSS did not demonstrate a long-term benefit for weight loss in either adults or children. While some clinical trial data indicated that higher intakes of NSS could lead to a reduction in overall calorie intake when they substituted for sugar or sugar-sweetened foods and beverages, this effect was not consistently linked to sustained weight reduction over time.
Furthermore, the review found no significant impact of NSS on levels of hunger or satiety. Some studies within the analysis suggested a reduction in hunger with NSS consumption, but others reported an increased appetite among participants who consumed higher quantities of NSS-containing beverages. This variability in findings suggests that individual responses to NSS may differ, and their impact on appetite regulation is not a universally predictable outcome.
Observational Data Links NSS to Increased Disease Risk
Beyond the findings on weight management, the WHO’s review also incorporated data from observational cohort studies. These studies, which track large groups of people over extended periods, revealed a concerning association between the long-term consumption of NSS-containing beverages and an increased risk of cardiovascular disease and premature death in adults. Similarly, higher intakes of NSS, whether added to foods or consumed in beverages, were linked to a greater likelihood of developing type 2 diabetes.
It is important to note that the WHO acknowledged the potential for "reverse causation" in these observational findings. This phenomenon suggests that individuals who are already at higher risk for chronic diseases, perhaps due to pre-existing obesity or metabolic risk factors, may be more inclined to choose NSS as a perceived healthier alternative to sugar. In such cases, the NSS consumption might be a consequence of, rather than a cause of, the underlying health conditions. The WHO’s analysis did not find a statistically significant association between NSS consumption and cancer or cancer-related deaths.
Based on this multifaceted evidence, the WHO strongly recommends that individuals aim to reduce the overall sweetness in their diets, beginning from an early age. The organization emphasizes that NSS do not offer nutritional value and, therefore, do not contribute positively to health. Examples of NSS covered by the guideline include acesulfame K, aspartame, saccharin, sucralose, and stevia. The analysis, however, did not include sugar alcohols (polyols) such as maltitol, xylitol, and sorbitol, which are commonly found in many food and beverage products.
Expert Perspectives and Criticisms
Experts from the Harvard T.H. Chan School of Public Health largely concurred with the WHO’s recommendation to reduce dietary sweetness. However, they also offered critiques of the meta-analysis, particularly regarding the exclusion of certain large-scale studies. These omitted cohort studies, which collectively involved over 100,000 participants, had indicated that increasing the consumption of artificially sweetened beverages in place of sugar-sweetened beverages was associated with less weight gain over time. This finding was consistent with results from smaller, short-term randomized controlled trials. Statistical modeling based on these excluded studies even estimated that substituting one serving of a sugar-sweetened beverage with an artificially sweetened one could be linked to a 4% lower risk of total mortality, a 5% lower risk of cardiovascular disease-related mortality, and a 4% lower risk of cancer-related mortality.
Dr. Frank Hu, Chair of the Department of Nutrition at the Harvard T.H. Chan School of Public Health, commented on the optimal beverage choices for long-term health. He stated, "For habitual consumers of sugar-sweetened beverages, artificially sweetened beverages can be used as a temporary replacement, although the best choices would be water and unsweetened coffee or tea." This perspective highlights the potential role of NSS as a transitional tool for individuals seeking to reduce sugar intake, while underscoring that water and unsweetened beverages remain the gold standard for optimal health.
A Look at Aspartame: Continued Scrutiny and Safety Guidelines
In a related development, the International Agency for Research on Cancer (IARC), in conjunction with the WHO and the Joint Expert Committee on Food Additives (JECFA), recently released a risk assessment of aspartame and cancer. Aspartame was classified as a Group 2B carcinogen, indicating "limited evidence" of carcinogenicity in humans, specifically concerning liver cancer.
Despite this classification, the established acceptable daily intake (ADI) for aspartame of 40 mg per kilogram of body weight remained unchanged. The committees noted that their research review did not present evidence that warranted altering this guideline, affirming that consumption within this range is considered safe. For an average 150-pound (68 kg) woman, this translates to a daily limit of approximately 2,727 mg of aspartame, equivalent to about eleven 12-ounce cans of diet soda, as a single can typically contains around 250 mg of aspartame. The agencies emphasized that the evidence on cancer risk in humans, based on both animal and human studies, was not yet convincing and that further research, particularly longer-term studies with comprehensive follow-up and randomized controlled trials, is needed to draw more definitive conclusions.
Broader Implications and Public Health Messaging
The WHO’s latest guideline on non-sugar sweeteners carries significant implications for public health policy, dietary recommendations, and consumer choices. The organization’s stance directly challenges the prevalent marketing of NSS as a straightforward solution for weight management and disease prevention. Instead, the WHO is advocating for a more fundamental approach: a reduction in the overall preference for sweet tastes.
This recommendation is particularly relevant in an era characterized by widespread availability and consumption of ultra-processed foods and beverages, many of which contain added sugars or NSS. The long-term health consequences of high sugar intake are well-documented, contributing to a global epidemic of obesity, type 2 diabetes, and cardiovascular disease. While NSS emerged as an appealing alternative, the WHO’s findings suggest that their role in mitigating these health crises may be less impactful than previously assumed, and potentially even carry their own set of risks, particularly with long-term, high-level consumption.
The emphasis on reducing overall sweetness from an early age is a proactive public health strategy. Childhood is a critical period for establishing dietary habits, and developing a palate that is less reliant on intense sweetness can lead to healthier eating patterns throughout life. This approach aligns with broader recommendations for promoting whole, unprocessed foods and discouraging reliance on products engineered for heightened palatability through artificial means.
The divergence in findings between the WHO’s analysis and some of the larger, excluded cohort studies highlights the complexities of nutritional research and the challenges of drawing definitive conclusions from observational data. While randomized controlled trials provide stronger evidence for causality, they are often limited in duration and scope. Observational studies, while subject to biases like reverse causation, can offer valuable insights into long-term trends and associations in real-world settings. The debate surrounding the interpretation and inclusion of different study types underscores the ongoing scientific discourse in this field.
Ultimately, the WHO’s guideline serves as a call to re-evaluate our relationship with sweeteners, both natural and artificial. It encourages a shift in focus from simply substituting one type of sweetener for another, to cultivating a more balanced and less sugar-dependent dietary pattern. The recommendation to prioritize water and unsweetened beverages as the primary hydration sources remains a cornerstone of healthy living, and the WHO’s latest pronouncements reinforce this foundational advice. As consumers navigate the complex landscape of food choices, this guidance provides a clearer, albeit more challenging, path toward improved long-term health.
